Medicis won't raise$2.8B Inamed offer

Medicis has chosen not to pursue a buyout of Inamed after offering $2.8 billion for the company in March 2005. Botox-maker Allergan trumped Medicis' by offering to buy Inamed for a substantially higher price--$3.2 billion. Inamed will pay Medicis a $90 million termination fee.

- read this AP report

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.